Neurovascular Devices Market
Neurovascular Devices Market
The market for Neurovascular Devices was estimated at $3.87 billion in 2024; it is anticipated to increase to $5.3 billion by 2030, with projections indicating growth to around $7.0 billion by 2035.
Global Neurovascular Devices Market Outlook
Revenue, 2024 (US$B)
Forecast, 2034 (US$B)
CAGR, 2024 - 2034
Market Key Insights
- The Neurovascular Devices market is projected to grow from $3.9 billion in 2024 to $6.6 billion in 2034. This represents a CAGR of 5.5%, reflecting rising demand across Stroke Management, Carotid Artery Stenosis Therapy and Intracranial Aneurysm Treatment.
- Medtronic plc, Stryker Corporation, Johnson & Johnson are among the leading players in this market, shaping its competitive landscape.
- U.S. and Germany are the top markets within the Neurovascular Devices market and are expected to observe the growth CAGR of 3.6% to 5.3% between 2024 and 2030.
- Emerging markets including Brazil, India and South Africa are expected to observe highest growth with CAGR ranging between 6.3% to 7.6%.
- Transition like Increased Adoption of Neurovascular Devices is expected to add $400.0 million to the Neurovascular Devices market growth by 2030
- The Neurovascular Devices market is set to add $2.7 billion between 2024 and 2034, with manufacturer targeting Flow Diversion & Neurothrombectomy Product Type projected to gain a larger market share.
- With Increased incidence of neurovascular diseases, and Advancements in technology, Neurovascular Devices market to expand 71% between 2024 and 2034.
Opportunities in the Neurovascular Devices
A rising pattern in the field of neurovascular devices involves the creation of stents that are bioresorbable or biodegradable in nature. These specialized devices are engineered to dissolve once their intended function is fulfilled thereby diminishing the potential, for enduring complications linked to permanent neurovascular devices.
Growth Opportunities in North America and Europe
North America Outlook
Europe Outlook
Market Dynamics and Supply Chain
Driver: Increased Incidence of Neurovascular Diseases, and Rising Healthcare Expenditure
Restraint: Stringent Regulatory Policies
Opportunity: Advancements in Robotics and Enhancement in Telemedicine
Challenge: High Cost of Devices and Procedures
Supply Chain Landscape
SGS S.A.
Bureau Veritas SA
Stryker Corporation
Medtronic
Boston Scientific Corporation
Johnson & Johnson Services Inc.
Smith & Nephew PLC
B. Braun Melsungen AG
Cardinal Health
SGS S.A.
Bureau Veritas SA
Stryker Corporation
Medtronic
Boston Scientific Corporation
Johnson & Johnson Services Inc.
Smith & Nephew PLC
B. Braun Melsungen AG
Cardinal Health